The “LIPUS-Brain transcranial Low-intensity pulsed ultrasound therapy device (LIPUS-Brain)” for the treatment of patients with early Alzheimer’s disease, which has been developed by Sound Wave Innovation Co., Ltd. and a research group (Tohoku University) led by Professor Hiroaki Shimokawa, founder and chairman of the board of SWI, was designated by the Ministry of Health, Labor and Welfare (MHLW) as an eligible product under the “Breakthrough Medical Devices, In Vitro Diagnostic Products and Regenerative Medicine Products Designation System as of September 30, 2022.

Breakthrough Medical Device Designation Program
designation letter

Contact :
Sound Wave Innovation Co., Ltd.
mail：info@sw-innovation.com